SAM:NYE-Boston Beer Company Inc (USD)

COMMON STOCK | Beverages - Brewers |

Last Closing

USD 271.33

Change

-9.09 (-3.24)%

Market Cap

N/A

Volume

0.15M

Analyst Target

USD 836.31
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Beverages - Brewers

Symbol Name Price(Change) Market Cap
FMX Fomento Economico Mexicano

-0.24 (-0.24%)

USD 176.52B
BUD Anheuser Busch Inbev NV ADR

-1.38 (-2.08%)

USD 130.99B
ABEV Ambev SA ADR

-0.06 (-2.43%)

USD 38.84B
TAP-A Molson Coors Beverage Company

N/A

USD 11.68B
TSI TCW Strategic Income Closed Fu..

-0.01 (-0.20%)

USD 10.66B
CCU Compania Cervecerias Unidas SA..

-0.08 (-0.72%)

N/A
TAP Molson Coors Brewing Co Class ..

-1.03 (-1.84%)

N/A

ETFs Containing SAM

BAD 2.60 % 0.00 %

N/A

N/A
EQWS 0.00 % 0.25 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

-0.52 (0%)

USD 5.65B

Market Performance

  Market Performance vs. Industry/Classification (Beverages - Brewers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.49% 50% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.49% 50% F 17% F
Trailing 12 Months  
Capital Gain -24.15% 50% F 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -24.15% 50% F 15% F
Trailing 5 Years  
Capital Gain -29.04% 75% C 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.04% 75% C 22% F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector